Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Neo Performance Materials Inc. (NEO.TO)
Toronto, ON, CA
Neo Performance Materials Inc. is a global company that manufactures and sells a diverse range of specialized products, including rare earth elements, magnetic powders, various types of magnets, and functional materials based on rare metals. The company's operations are divided into three key segments: Magnequench, Chemicals and Oxides, and Rare Metals. The Magnequench division focuses on producing magnetic powders essential for creating bonded and hot-deformed, fully dense neodymium-iron-boron magnets. These advanced powders are critical components in permanent magnets utilized across numerous applications, such as automotive motors, micro motors, traction systems, and sensing devices. The Chemicals and Oxides segment is responsible for the production and distribution of a wide array of industrial materials. These materials find application in automotive catalysts, petroleum refining and other chemical catalysis, magnet manufacturing, hybrid and electric vehicles, water treatment processes, consumer electronics, and more. The Rare Metals segment manages the sourcing, production, reclamation, refining, and marketing of high-temperature metals, including tantalum, niobium, hafnium, and rhenium, as well as electronic metals like gallium and indium. The output from this segment is used in high-performance super alloys for jet engines, medical imaging technology, wireless communications, LED lighting, flat panel displays, solar energy, steel additives, batteries, and various electronic applications. Founded in 1994, Neo Performance Materials Inc. is based in Toronto, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.12% | +5.33% | +37.49% | +52.76% | +97.22% | +109.51% | +221.50% | +289.49% | +82.12% | +85.23% | +85.23% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+2.4% Q1'26: +25.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+22.6% ★ Q1'26: +2.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-16.9% Q1'26: -29.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+6.6% Q1'26: +17.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.2% Q1'26: +12.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-1.5% ★ Q1'26: -0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.21× Q1'26: 1.33× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 2 EPS Ana. |
Dec 2027 5 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
434.17M
est: 430.86M (+0.8%)
|
454.20M
est: 460.89M (-1.5%)
|
407.46M
est: 404.53M (+0.7%)
|
346.69M
est: 322.89M (+7.4%)
|
539.25M
est: 507.70M (+6.2%)
|
640.30M
est: 628.26M (+1.9%)
|
571.55M
est: 495.23M (+15.4%)
|
475.83M
est: 450.83M (+5.5%)
|
487.17M
est: 470.37M (+3.6%)
|
578.12M
555.98M – 612.07M
+22.9% YoY
|
613.10M
565.82M – 677.91M
+6.1% YoY
|
660.29M
654.94M – 665.65M
+7.7% YoY
|
| EBITDA |
52.34M
est: 29.77M (+75.8%)
|
61.97M
est: 31.85M (+94.6%)
|
53.09M
est: 27.95M (+89.9%)
|
18.29M
est: 22.31M (-18.0%)
|
57.99M
est: 35.08M (+65.3%)
|
59.05M
est: 43.41M (+36.0%)
|
23.67M
est: 38.67M (-38.8%)
|
24.54M
est: 35.20M (-30.3%)
|
47.58M
est: 36.73M (+29.5%)
|
45.14M
43.41M – 47.79M
+22.9% YoY
|
47.87M
44.18M – 52.93M
+6.1% YoY
|
51.56M
51.14M – 51.98M
+7.7% YoY
|
| EBIT |
34.83M
est: 15.33M (+127.2%)
|
40.88M
est: 16.40M (+149.3%)
|
35.09M
est: 14.39M (+143.8%)
|
-59.29M
est: 11.49M (-616.1%)
|
42.13M
est: 18.06M (+133.2%)
|
42.33M
est: 22.35M (+89.4%)
|
6.85M
est: 23.87M (-71.3%)
|
8.80M
est: 21.73M (-59.5%)
|
32.31M
est: 22.68M (+42.5%)
|
27.87M
26.80M – 29.51M
+22.9% YoY
|
29.56M
27.28M – 32.68M
+6.1% YoY
|
31.83M
31.57M – 32.09M
+7.7% YoY
|
| Net Income |
24.62M
est: 36.50M (-32.5%)
|
40.80M
est: 43.53M (-6.3%)
|
22.92M
est: 25.21M (-9.1%)
|
-61.15M
est: 760.6K (-8,139.1%)
|
35.18M
est: 53.62M (-34.4%)
|
25.95M
est: 41.24M (-37.1%)
|
-8.44M
est: 3.43M (-345.8%)
|
-12.95M
est: 10.17M (-227.3%)
|
-10.16M
est: 23.36M (-143.5%)
|
53.81M
37.60M – 70.03M
+130.3% YoY
|
59.00M
57.15M – 60.85M
+9.6% YoY
|
103.81M
94.43M – 113.19M
+75.9% YoY
|
| SGA |
69.46M
est: 52.69M (+31.8%)
|
53.38M
est: 56.36M (-5.3%)
|
42.71M
est: 49.47M (-13.7%)
|
55.44M
est: 39.49M (+40.4%)
|
62.97M
est: 62.09M (+1.4%)
|
61.40M
est: 76.83M (-20.1%)
|
59.12M
est: 60.52M (-2.3%)
|
64.46M
est: 55.09M (+17.0%)
|
77.68M
est: 57.48M (+35.1%)
|
70.65M
67.94M – 74.80M
+22.9% YoY
|
74.92M
69.15M – 82.84M
+6.1% YoY
|
80.69M
80.04M – 81.34M
+7.7% YoY
|
| EPS |
0.62
est: 0.86 (-28.1%)
|
1.02
est: 1.03 (-0.8%)
|
0.59
est: 0.60 (-0.9%)
|
-1.63
est: 0.02 (-9,173.8%)
|
0.92
est: 1.27 (-27.4%)
|
0.62
est: 0.97 (-36.3%)
|
-0.19
est: 0.08 (-335.8%)
|
-0.30
est: 0.24 (-225.0%)
|
-0.24
est: 0.55 (-143.5%)
|
1.19
0.90 – 1.68
+115.0% YoY
|
1.42
1.37 – 1.46
+19.5% YoY
|
2.45
2.26 – 2.71
+72.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Rahim Suleman | Chief Executive Officer, President & Director | 3M | male |
| Kevin D. Morris | Executive Vice President & Chief Strategy Officer | 1M | male |
| Gregory K. Kroll | Executive Vice President of Magnequench | 1M | male |
| Mohamad El- Mahmoud | Executive Vice President of Chemical and Oxides & Rare Metals | 964.5K | male |
| Jonathan Baksh | Executive Vice President & Chief Financial Officer | 798.7K | male |
| Karen A. Murray | Senior Vice President & General Counsel | — | female |
| Jim Fitzpatrick | Senior Vice President of Investor Relations & Communications | — | — |
| Alexander D. Caldwell | Corporate Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NEO.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
